×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Pr Jean-Emmanuel Kurtz (ICANS Strasbourg)

18:00
Introduction du partenariat avec le Cancéropôle
Rachel Groubet (Cancéropôle Est)
 
18:05
Les ADCs Anti-HER2, mécanismes d’action & de résistance et solutions d’après
Pr Sylvain Ladoire (CGFL Dijon)
 
18:20
Les inhibiteurs de tyrosine kinase Anti-HER2, classe thérapeutique à part entière, du mécanisme d’action à l’effet thérapeutique
Pr Thierry Petit (ICANS Strasbourg)
 
 
18:35
Cas clinique/Synthèse des stratégies thérapeutiques actuelles et perspectives
Dr Isabelle Desmoulins & Pr Sylvain Ladoire (CGFL Dijon)
 
18:50
Débat/Discussion - Réponses aux questions
Ensemble des intervenants
 
  
Shooting date : 2022-10-13
Last update : 2022-10-14

Suggestions

Tuesday, February 4th 2025 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, February 4th 2025 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, February 4th 2025 from 08am to 09:30am (GMT+1)
New York : Tuesday, February 4th 2025 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, February 4th 2025 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, February 4th 2025 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, February 4th 2025 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, February 4th 2025 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, February 4th 2025 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, February 4th 2025 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, February 5th 2025 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, February 5th 2025 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, February 5th 2025 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, February 5th 2025 from 04am to 05:30am (GMT+1)

Prise en charge du cancer du sein métastatique HER2 surexprimé

Share
Tuesday, March 25th 2025 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, March 25th 2025 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, March 25th 2025 from 08am to 09:30am (GMT+1)
New York : Tuesday, March 25th 2025 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, March 25th 2025 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, March 25th 2025 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, March 25th 2025 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, March 25th 2025 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, March 25th 2025 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, March 25th 2025 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, March 26th 2025 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, March 26th 2025 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, March 26th 2025 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, March 26th 2025 from 04am to 05:30am (GMT+1)

Où en sommes-nous dans la prise en charge du cancer du sein ?

au stade métastatique RH+/HER2- ou HER2+

Share
Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Honolulu : Thursday, March 10th 2022 from 07am to 09am (GMT+1)
San Francisco : Thursday, March 10th 2022 from 09am to 11am (GMT+1)
New York : Thursday, March 10th 2022 from 12pm to 02pm (GMT+1)
Buenos Aires : Thursday, March 10th 2022 from 02pm to 04pm (GMT+1)
London / Dublin : Thursday, March 10th 2022 from 05pm to 07pm (GMT+1)
Paris / Berlin : Thursday, March 10th 2022 from 06pm to 08pm (GMT+1)
Istanbul : Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Moscou / Dubaï : Thursday, March 10th 2022 from 09pm to 11pm (GMT+1)
Bangkok : Friday, March 11th 2022 from 12am to 02am (GMT+1)
Shanghai : Friday, March 11th 2022 from 01am to 03am (GMT+1)
Tokyo : Friday, March 11th 2022 from 02am to 04am (GMT+1)
Sydney : Friday, March 11th 2022 from 03am to 05am (GMT+1)
Wellington : Friday, March 11th 2022 from 05am to 07am (GMT+1)

Changement de paradigme dans les cancers du sein triple négatif métastatique - de la théorie à l...

Share
Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, May 10th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Wednesday, May 10th 2023 from 09am to 10:30am (GMT+2)
New York : Wednesday, May 10th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Wednesday, May 10th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Wednesday, May 10th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Wednesday, May 10th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Wednesday, May 10th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Wednesday, May 10th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Wednesday, May 10th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Thursday, May 11th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Thursday, May 11th 2023 from 01am to 02:30am (GMT+2)
Sydney : Thursday, May 11th 2023 from 03am to 04:30am (GMT+2)
Wellington : Thursday, May 11th 2023 from 05am to 06:30am (GMT+2)

Cancer du sein : actualités et essais en cours, vers où allons-nous ?

Share
Scroll Up